Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Emerging Markets Earnings Roundup: Roche, Johnson & Johnson, Abbott (Part 1)

Oct 30 2012

• By Tamra Sami

Related Content

As AbbVie Prepares To Launch, Some Wind Gets Knocked Out Of Its Sails

Oct 22 2012

Roche Oncology Turns In A Third Quarter To Rival The Good Old Days

Oct 22 2012

J&J Under CEO Gorsky Will Remain Diverse But Be More Selective

Jul 17 2012

J&J Opens Device R&D Center In China For Growing Rural Market

Jul 01 2011

Follow The CEO? Abbott Chief Chooses Diversified Products, Emerging Markets Over Rx Drugs As Company Splits In Two

Oct 20 2011

J&J Sprouts New Innovation Centers In Industry Hot Spots

Sep 24 2012

Related Companies

Roche Holding AG

Johnson & Johnson

Abbott

AstraZeneca PLC

Dr. Reddy's Laboratories Ltd.

Emcure Pharmaceuticals Pvt Ltd.

Johnson & Johnson

Gilead Sciences, Inc.

Samsung Bioepis Co., Ltd.

NPO Petrovax Pharm LLC

Reata Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

Astellas Pharma, Inc.

Johnson & Johnson

Additional Topics

Asia Pacific Emerging Markets BioPharmaceutical Medical Device

More from Focus On Asia

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window